Skip to main content

Table 2 Primary and secondary efficacy outcomes based on infection with malaria in early pregnancy

From: The efficacy of low-dose aspirin in pregnancy among women in malaria-endemic countries

Variable

Overall

Malaria Negative

Malaria Positive

Aspirin ā€“ Malaria InteractionĀ p-value

n/N (%)

PR (95% CI)

n/N (%)

PR (95% CI)

n/N (%)

PR (95% CI)

Primary Outcome

Ā Preterm delivery

Ā Ā Aspirin

83/724 (11)

0Ā·92 (0Ā·70, 1Ā·22)

38/445 (9)

0Ā·89 (0Ā·59, 1Ā·36)

45/279 (16)

0Ā·95 (0Ā·66, 1Ā·38)

0.75

Ā Ā Placebo

90/722 (12)

Ā 

42/439 (10)

Ā 

48/283 (17)

Ā Ā 

Hypertensive disorders

Ā Aspirin

10/724 (1)

1Ā·11 (0Ā·45, 2Ā·71)

8/445 (2)

0Ā·88 (0Ā·34, 2Ā·25)

2/279 (1)

5Ā·07 (0Ā·24, 105Ā·17)

ā€“

Ā Placebo

9/722 (1)

Ā 

9/439 (2)

Ā 

0/283 (0)

Ā Ā 

Small for gestational age

Ā Aspirin

89/686 (13)

1Ā·11 (0Ā·84, 1Ā·48)

58/421 (14)

1Ā·21 (0Ā·84, 1Ā·73)

31/265 (12)

0Ā·97 (0Ā·61, 1Ā·54)

0.62

Ā Placebo

78/668 (12)

Ā 

46/403 (11)

Ā 

32/265 (12)

Ā Ā 

Perinatal mortality

Ā Aspirin

41/724 (6)

0Ā·95 (0Ā·63, 1Ā·44)

16/445 (4)

0Ā·56 (0Ā·31, 1Ā·03)

25/279 (9)

1Ā·69 (0Ā·91, 3Ā·14)

0.014

Ā Placebo

43/722 (6)

Ā 

28/439 (6)

Ā 

15/283 (5)

Ā Ā 

Other Maternal Outcomes of Interest

Ā Vaginal bleeding

Ā Ā Aspirin

12/713 (2)

0Ā·86 (0Ā·40, 1Ā·85)

11/437 (3)

0Ā·91 (0Ā·41, 2Ā·05)

1/276 (0)

0Ā·51 (0Ā·05, 5Ā·56)

0.64

Ā Ā Placebo

14/715 (2)

Ā 

12/435 (3)

Ā 

2/280 (1)

Ā Ā 

Antepartum hemorrhage

Ā Aspirin

4/721 (1)

8Ā·95 (0Ā·48, 165Ā·94)

4/442 (1)

8Ā·86 (0Ā·48, 164Ā·04)

0/279 (0)

1Ā·01 (0Ā·02, 50Ā·76)

ā€“

Ā Placebo

0/717 (0)

Ā 

0/435 (0)

Ā 

0/282 (0)

Ā Ā 

Postpartum hemorrhage

Ā Aspirin

6/724 (1)

2Ā·99 (0Ā·61, 14Ā·77)

2/445 (0)

4Ā·93 (0Ā·24, 102Ā·46)

4/279 (1)

2Ā·03 (0Ā·37, 10Ā·99)

ā€“

Ā Placebo

2/722 (0)

Ā 

0/439 (0)

Ā 

2/283 (0)

Ā Ā 

Maternal mortality through 42Ā days

Ā Aspirin

0/724 (0)

0Ā·33 (0Ā·02, 8Ā·15)

0/445 (0)

0Ā·33 (0Ā·02, 8Ā·05)

0/279 (0)

1Ā·01 (0Ā·02, 50Ā·94)

ā€“

Ā Placebo

1/722 (0)

Ā 

1/439 (0)

Ā 

0/283 (0)

Ā Ā 

Preterm and hypertensive disorders

Aspirin

1/724 (0)

2Ā·99 (0Ā·12, 73Ā·32)

0/445 (0)

0Ā·99 (0Ā·02, 49Ā·61)

1/279 (0)

3Ā·04 (0Ā·12, 74Ā·38)

ā€“

Placebo

0/722 (0)

Ā 

0/439 (0)

Ā 

0/283 (0)

Ā Ā 

Other Fetal Outcomes of Interest

Ā Pretermā€‰<ā€‰34Ā weeks of pregnancy

Ā Ā Aspirin

30/724 (4)

0Ā·88 (0Ā·54, 1Ā·42)

15/445 (3)

0Ā·74 (0Ā·38, 1Ā·43)

15/279 (5)

1Ā·09 (0Ā·53, 2Ā·21)

0.40

Ā Ā Placebo

34/722 (5)

Ā 

20/439 (5)

Ā 

14/283 (5)

Ā Ā 

Birth weightā€‰<ā€‰2500Ā g

Ā Aspirin

76/715(11)

0Ā·94 (0Ā·70, 1Ā·27)

37/439 (8)

0Ā·91 (0Ā·59, 1Ā·39)

39/276 (14)

0Ā·98 (0Ā·65, 1Ā·47)

0.69

Ā Placebo

80/708 (11)

Ā 

40/432 (9)

Ā 

40/276 (15)

Ā Ā 

Birth weightā€‰<ā€‰1500Ā g

Ā Aspirin

9/715 (1)

0Ā·69 (0Ā·29, 1Ā·59)

1/439 (0)

0Ā·10 (0Ā·01, 0Ā·77)

8/276 (3)

2Ā·67 (0Ā·71, 9Ā·95)

0.007

Ā Placebo

13/708 (2)

Ā 

10/432 (2)

Ā 

3/276 (1)

Ā Ā 

Stillbirth

Ā Aspirin

14/718 (2)

0Ā·87 (0Ā·43, 1Ā·76)

8/442 (2)

0Ā·87 (0Ā·34, 2Ā·23)

6/276 (2)

0Ā·87 (0Ā·30, 2Ā·55)

0.99

Ā Placebo

16/712 (2)

Ā 

9/432 (2)

Ā 

7/280 (3)

Ā Ā 

Malaria in late pregnancy (26ā€“30Ā weeks)

Ā Aspirin

92/296 (31)

1Ā·13 (0Ā·88, 1Ā·45)

42/177 (24)

1Ā·42 (0Ā·93, 2Ā·15)

50/119 (42)

0Ā·94 (0Ā·70, 1Ā·26)

0.15

Ā Placebo

83/301 (28)

Ā 

31/185 (17)

Ā 

52/116 (45)

Ā Ā